14 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
, comparison and ... considerations #pharmacology ... #table #medications ... #comparison #drugs ... #treatment #pharmacotherapy
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... anti-inflammatory drugs ... NSAIDS #management #pharmacology ... #table #comparison ... #medications #treatment
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Arrhythmias / CHB ... Pericardial tamponade, Pulmonary ... pharmacology ... diagnosis #management #comparison ... #table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... Drug interactions ... #pharmacology #comparison ... #treatment #medications ... #table #pharmacotherapy
Potassium Binders for Management of Hyperkalemia
 • SPS - Sodium polystyrene sulfonate
 • Patiromer (veltassa)
 •
Management of Hyperkalemia ... Binders #Management #Hyperkalemia ... #treatment #pharmacology ... #table #comparison
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... from other oral drugs ... patients with CKD, HF ... this from other drugs ... #Pharmacology
Approach to Eosinophilic Lung Diseases
 • Acute Eosinophilic Pneumonia (< 1 wk) - ~30yo, M; Recent
Hx of asthma, CF ... Fever, wheezing • Drug ... Lung #Diseases #pulmonary ... differential #diagnosis #comparison ... #table #eosinophilia
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Hyperkalemia - Diagnosis ... Na delivery): CHF ... draw, ↑↑Plts or ↑↑WBC ... Elimination (see Table ... Redistribution Treatments
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: 33% • Treatment ... : Age>60, CKD, CHF ... , and CXR with pulmonary ... hematology #diagnosis #comparison ... #table
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... • Therapeutic drug ... valleyfever #management #treatment ... #antifungals #comparison ... #table #pharmacology